Targeted Lung Denervation for Patients With Moderate to Severe COPD

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

August 4, 2014

Primary Completion Date

January 26, 2018

Study Completion Date

June 16, 2020

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DEVICE

Holaira™ Lung Denervation System with energy delivery

DEVICE

Holaira™ Lung Denervation System without energy delivery

Trial Locations (18)

1000

CHU Saint Pierre, Brussels

1140

Otto-Wagner-Spital, Vienna

3000

University Hospital Leuven, Leuven

9700

Universtity Medical Center Groningen, Groningen

13353

Charite-Universitatsmedizin Berlin, Berlin

38700

CHU de Grenoble, Grenoble

45239

Ruhrlandklinik - West German Lung Center, Essen

51092

CHU de Reims, Reims

59000

CHU de Lille, Lille

67000

CHU de Strasbourg, Strasbourg

82131

Asklepios-Fachkliniken, Gauting

87509

Klinikverbund Kempten-Oberallgaeu, Kempten

Unknown

AKH Allgemeines Krankenhaus der Stadt Linz GmbH, Linz

CHU de Paris - Hopital Bichat Claude Bernard, Paris

Universitatklinikum Bonn, Bonn

Academic Medical Center, Amsterdam

D-69126

Thoraxklinik Heidelberg, Heidelberg

SW3,6NY

Royal Brompton, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nuvaira, Inc.

INDUSTRY

NCT02058459 - Targeted Lung Denervation for Patients With Moderate to Severe COPD | Biotech Hunter | Biotech Hunter